Home » Benefits of Merck HIV Drug Outweigh Risks, FDA Says
Benefits of Merck HIV Drug Outweigh Risks, FDA Says
The Food and Drug Administration said Friday that the benefits of a proposed HIV drug from Merck & Co. outweigh “the currently identified risks.”
The Wall Street Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May